{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:17:26Z","timestamp":1792052246652,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ard.2026.01.016","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:33:48Z","timestamp":1773664428000},"page":"1163-1171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0201-0686","authenticated-orcid":false,"given":"Ann-Christin","family":"Pecher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marouane","family":"Boubaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska","family":"de Vries-Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radim","family":"Be\u010dv\u00e1\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Moroncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathi","family":"Nihal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotyla","family":"Przemyslaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Gado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Elhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10373","key":"10.1016\/j.ard.2026.01.016_bib0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ard.2026.01.016_bib0002","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2026.01.016_bib0003","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s10067-025-07557-y","article-title":"Stem cell therapy in systemic sclerosis","volume":"44","author":"Sakkas","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ard.2026.01.016_bib0004","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1097\/RHU.0000000000002253","article-title":"Predictors of persistent disease activity and damage in systemic sclerosis: associations with mortality in a single-center cohort study","volume":"31","author":"Moccaldi","year":"2025","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2026.01.016_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41584-024-01217-2","article-title":"An international perspective on the future of systemic sclerosis research","volume":"21","author":"Abraham","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ard.2026.01.016_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114071","article-title":"Application of blinatumomab, a bispecific anti-CD3\/CD19 T-cell engager, in treating severe systemic sclerosis: a case study","volume":"204","author":"Subklewe","year":"2024","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ard.2026.01.016_bib0007","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ard.2025.01.043","article-title":"Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation","volume":"84","author":"Siegert","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2026.01.016_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ero.2025.03.005","article-title":"CD19-targeting CAR T cell therapy in five patients with systemic sclerosis unsuitable for autologous stem cell transplantation","author":"Pecher","year":"2025","journal-title":"EULAR Rheumatol Open"},{"issue":"2","key":"10.1016\/j.ard.2026.01.016_bib0009","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2665-9913(24)00282-0","article-title":"CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series","volume":"7","author":"Auth","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"18","key":"10.1016\/j.ard.2026.01.016_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ard.2026.01.016_bib0011","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(25)00159-6","article-title":"Persisting CD19.CAR-T cells in combination with nintedanib: clinical response in a patient with systemic sclerosis-associated pulmonary fibrosis after 2 years","volume":"13","author":"Merkt","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ard.2026.01.016_bib0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party","volume":"106","author":"Henes","year":"2021","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.ard.2026.01.016_bib0013","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/annrheumdis-2020-217058","article-title":"Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study","volume":"79","author":"van Bijnen","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2026.01.016_bib0014","doi-asserted-by":"crossref","first-page":"rkad101","DOI":"10.1093\/rap\/rkad101","article-title":"Stem cell-based therapy for systemic sclerosis","volume":"7","author":"Zare Moghaddam","year":"2023","journal-title":"Rheumatol Adv Pract"},{"issue":"1","key":"10.1016\/j.ard.2026.01.016_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22161-9","article-title":"Development and validation of machine learning for early mortality in systemic sclerosis","volume":"12","author":"Foocharoen","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ard.2026.01.016_bib0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2397198319869564","article-title":"Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis","volume":"5","author":"van den Hombergh","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"issue":"8","key":"10.1016\/j.ard.2026.01.016_bib0017","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s10067-024-07039-7","article-title":"Prediction of prognosis in patients with systemic sclerosis based on a machine-learning model","volume":"43","author":"Zheng","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2026.01.016_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000113","article-title":"A prediction model for progressive disease in systemic sclerosis","volume":"1","author":"Meijs","year":"2015","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.ard.2026.01.016_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102507","article-title":"Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: derivation and internal validation","volume":"19","author":"Rubio-Rivas","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.ard.2026.01.016_bib0020","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41409-025-02695-y","article-title":"Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee","volume":"60","author":"Alexander","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ard.2026.01.016_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102476","article-title":"Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee","volume":"69","author":"Greco","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ard.2026.01.016_bib0022","article-title":"A systematic review of Machine Learning and Deep Learning approaches in Mexico: challenges and opportunities","volume":"7","author":"Uc Castillo","year":"2024","journal-title":"Front Artif Intell"},{"key":"10.1016\/j.ard.2026.01.016_bib0023","first-page":"191","article-title":"A review of challenges and opportunities in machine learning for health","volume":"2020","author":"Ghassemi","year":"2020","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"issue":"8","key":"10.1016\/j.ard.2026.01.016_bib0024","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2026.01.016_bib0025","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.01.016_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99215-x","article-title":"CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis","volume":"11","author":"Gieszczyk-Str\u00f3zik","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ard.2026.01.016_bib0027","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clnesp.2020.09.030","article-title":"Nutritional status and predictors of weight loss in patients with systemic sclerosis","volume":"40","author":"Hvas","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.ard.2026.01.016_bib0028","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1002\/ejhf.70061","article-title":"A U-shaped relationship between left ventricular ejection fraction and risk of worsening heart failure","volume":"27","author":"Chang","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.ard.2026.01.016_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.2420","article-title":"Sex-specific association of left ventricular function with mortality in severe mitral regurgitation","volume":"8","author":"Kwak","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.ard.2026.01.016_bib0030","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/eurheartj\/ehz550","article-title":"Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?","volume":"41","author":"Wehner","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ard.2026.01.016_bib0031","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/biomet\/asm037","article-title":"Adaptive lasso for Cox's proportional hazards model","volume":"94","author":"Zhang","year":"2007","journal-title":"Biometrika"},{"issue":"15","key":"10.1016\/j.ard.2026.01.016_bib0032","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.ard.2026.01.016_bib0033","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.140006","article-title":"The effect of male sex on survival in systemic sclerosis","volume":"41","author":"Hussein","year":"2014","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2026.01.016_bib0034","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3899\/jrheum.111582","article-title":"Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients","volume":"39","author":"Sampaio-Barros","year":"2012","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2026.01.016_bib0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res Ther"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:31:02Z","timestamp":1780864262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0003496726000658"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.01.016","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}